Stocks
Anika Therapeutics, Inc.ANIK
NASDAQHealthcareBiotechnology$20.86-0.70%
Price as of · delayed, not real-time
Specializing in regenerative therapies, this biotech firm develops products for tissue protection, repair, and pain management, primarily in orthopedics. Investors monitor its pipeline of osteoarthritis treatments and surgical recovery solutions given the growing demand for minimally invasive joint preservation options.
Market Cap: $204.8M52W Range: $8.52-$22.88
Congressional Interest in Anika Therapeutics, Inc. (ANIK)
2 members of Congress have disclosed 10 trades in Anika Therapeutics, Inc. (ANIK), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
10
Unique Politicians
2
Buys
7
Sells
3
Who in Congress Is Trading ANIK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-02 | Tom Malinowski | buy | $1K-$15K |
| 2020-02-28 | Tom Malinowski | buy | $1K-$15K |
| 2020-02-27 | Tom Malinowski | buy | $1K-$15K |
| 2020-02-26 | Tom Malinowski | buy | $15-$50 |
| 2020-02-26 | Tom Malinowski | buy | $15K-$50K |
| 2020-01-28 | Tom Malinowski | sell | $1K-$15K |
| 2019-10-29 | Tom Malinowski | sell | $1K-$15K |
| 2019-08-01 | Tom Malinowski | buy | $50K-$100K |
| 2019-07-29 | Tom Malinowski | sell | $1K-$15K |
| 2018-12-10 | JAMES B. RENACCI | buy | $15K-$50K |